Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies

Alzheimer's Reports

Volumn 1, Issue 3, 1998, Pages 159-163

  Armstrong, Richard A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22044445382     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Armstrong RA (1994). Differences in β-amyloid (β/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci Lett 169, 133-136.
2. Armstrong RA, Myers D and Smith CUM (1992). The distribution of senile plaques, neurofibrillary tangles and β/A4 protein in the hippocampus in Alzheimer's disease. Neurosci Res Commun 10, 87-94.
3. Armstrong RA, Cairns NJ and Lantos PL (1997a). β-amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 227, 193-196.
4. Armstrong RA, Cairns NJ and Lantos PL (1997b). Laminar distribution of cortical Lewy bodies and neurofibrillary tangles in Dementia with Lewy bodies. Neurosci Res Commun 21, 145-152.
5. Brion JP and Couck AM (1995). Cortical and brain stem type Lewy Bodies are immunoreactive for the cyclin dependent kinase-5. Am J Pathol 147, 1465-1476.
6. Dickson DW, Ruan D, Crystal H et al. (1991). Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscope immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology 41, 1402-1409.
7. Fukuda T, Tanaka J, Watabe K, et al. (1993). Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain stem in Lewy body disease. Acta Path Japon 43, 545-551.
8. Gai WP, Blumbergs PC and Blessing WW (1996). Microtubuleassociated protein-5 is a component of Lewy bodies and Lewy body neurites in the brain stem and forebrain regions affected in Parkinson's disease. Acta Neuropath 91, 78-81.
9. Galasko D, Katzman R, Salmon DP and Hansen I (1996). Clinical and neuropathological findings in Lewy Body dementias. Brain Cognit 31, 166-175.
10. Gibb WRG, Luthert PJ, Janota I and Lantos PL (1989). Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatr 52, 185-192.
11. Harrington CR, Perry RH, Perry EK et al. (1994). Senile dementia of the Lewy Body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphoshorylated tau proteins. Dementia 5, 215-228.
12. Hely MA, Reid WGJ, Halliday GM et al. (1996). Diffuse Lewy Body Disease: clinical features in nine cases without coexistent Alzheimer's disease. J Neurol Neurosurg Psychiatr 60, 531-538.
13. Iwatsubo T, Yamaguchi H, Fujinuro M et al. (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy Body disease. Am J Pathol 148, 1517-1529.
14. Kawanishi C, Suzuki K, Odawara T et al. (1996). Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 136, 140-142.
15. Love S and Nicoll JAR (1992). Comparison of modified Bielschowsky silver impregnation and antiubiquitin immunostaining of cortical and nigral Lewy bodies. Neuropath Appl Neurobiol 18, 585-592.
16. Lowe J, Mayer RJ and Landon M (1993). Ubiquitin in neurodegenerative diseases. Brain Path 3, 55-65.
17. Mann DMA and Snowden JS (1995). The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 89, 178-183.
18. McKeith IG, Perry RH, Fairbairn AF et al. (1992). Operational criteria for senile dementia of the Lewy body type (SDLT). Psychol Med 22, 911-922.
19. McKeith IG, Galasko D, Kosaka K et al. (1996). Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47, 1113-1124.
20. Mirra SS, Heyman A, McKeel D, et al. (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
21. Perry RH, Irving D, Blessed G et al. (1990). Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95, 119-139.
22. Pollanen MS, Bergeron C and Weyer L (1994). Characterisation of a shared epitope in cortical Lewy Body fibrils and Alzheimer paired helical filaments. Acta Neuropathol 88, 1-6.
23. Reyes E, Gamboa A and Masliah E (1993). Atypical diffuse Lewy body disease with neuritic abnormalities. Clin Neuropathol 12, 330-334.
24. Rezaie P, Cairns NJ, Chadwick A and Lantos PL (1996). Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 212, 111-114.
25. Salmon DP, Galasko D, Hansen LA et al. (1996). Neuropsychological deficits associated with diffuse Lewy Body Disease. Brain Cognit 31, 148-165.
26. Spillantini MG, Schmidt ML, Lee VMY et al. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
27. Sternberger LA (1986) Immunocytochemistry. 3rd Ed., Wiley Press, New York.